Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 1
1987 2
1988 1
1990 1
2001 1
2005 1
2010 2
2012 1
2014 1
2015 1
2016 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Phase 3 Trials of Ixekizumab in Moderate-to-Severe Plaque Psoriasis.
Gordon KB, Blauvelt A, Papp KA, Langley RG, Luger T, Ohtsuki M, Reich K, Amato D, Ball SG, Braun DK, Cameron GS, Erickson J, Konrad RJ, Muram TM, Nickoloff BJ, Osuntokun OO, Secrest RJ, Zhao F, Mallbris L, Leonardi CL; UNCOVER-1 Study Group; UNCOVER-2 Study Group; UNCOVER-3 Study Group. Gordon KB, et al. N Engl J Med. 2016 Jul 28;375(4):345-56. doi: 10.1056/NEJMoa1512711. Epub 2016 Jun 8. N Engl J Med. 2016. PMID: 27299809 Free article. Clinical Trial.
Cutaneous onchocerciasis.
Maso MJ, Kapila R, Schwartz RA, Wiltz H, Kaminski ZC, Lambert WC. Maso MJ, et al. Among authors: wiltz h. Int J Dermatol. 1987 Nov;26(9):593-6. doi: 10.1111/j.1365-4362.1987.tb02313.x. Int J Dermatol. 1987. PMID: 3443529
Delusions of parasitosis.
Wiltz H Jr, Lambert WC. Wiltz H Jr, et al. Ariz Med. 1984 Jun;41(6):379-82. Ariz Med. 1984. PMID: 6466130 No abstract available.
Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: Results from 2 randomized phase-III studies.
Elewski BE, Aly R, Baldwin SL, González Soto RF, Rich P, Weisfeld M, Wiltz H, Zane LT, Pollak R. Elewski BE, et al. Among authors: wiltz h. J Am Acad Dermatol. 2015 Jul;73(1):62-9. doi: 10.1016/j.jaad.2015.04.010. Epub 2015 May 5. J Am Acad Dermatol. 2015. PMID: 25956661 Free article. Clinical Trial.
Long-term safety of ivermectin 1% cream vs azelaic acid 15% gel in treating inflammatory lesions of rosacea: results of two 40-week controlled, investigator-blinded trials.
Stein Gold L, Kircik L, Fowler J, Jackson JM, Tan J, Draelos Z, Fleischer A, Appell M, Steinhoff M, Lynde C, Sugarman J, Liu H, Jacovella J; Ivermectin Phase 3 Study Group. Stein Gold L, et al. J Drugs Dermatol. 2014 Nov;13(11):1380-6. J Drugs Dermatol. 2014. PMID: 25607706 Clinical Trial.
Efficacy and safety of calcipotriene 0.005% foam for the treatment of plaque-type psoriasis: results of two multicenter, randomized, double-blind, vehicle-controlled, phase III clinical trials.
Feldman SR, Matheson R, Bruce S, Grande K, Markowitz O, Kempers S, Brundage T, Wyres M; U0267-301 & 302 Study Investigators. Feldman SR, et al. Am J Clin Dermatol. 2012 Aug 1;13(4):261-71. doi: 10.2165/11630710-000000000-00000. Am J Clin Dermatol. 2012. PMID: 22587791 Clinical Trial.
13 results